机译:用5-氮杂辛胺治疗的骨髓增生综合征高风险患者单体核型(MK)的预后价值:Hellenic(希腊语)骨髓增强综合征研究组的回顾性分析
Univ Gen Hosp Attikon Dept Internal Med 2 1 Rimini St Athens 12462 Greece;
Univ Gen Hosp Attikon Dept Internal Med 2 1 Rimini St Athens 12462 Greece;
Univ Athens Dept Biochem &
Mol Biol Athens 15701 Greece;
Democritus Univ Thrace Univ Hosp Alexandroupolis Dept Hematol Sch Med Alexandroupolis Greece;
Hellen Greek MDS Study Grp Patras 26500 Greece;
Hellen Greek MDS Study Grp Patras 26500 Greece;
Univ Hosp Ioannina Ioannina 45100 Greece;
Metaxa Piraeus Canc Hosp Dept Hematol Piraeus Greece;
401 Army Gen Hosp Athens Mesoge &
Kanellopoulou 1 Athens 11525 Greece;
Univ Athens Dept Internal Med 1 Athens Greece;
Univ Athens Laikon Gen Hosp Dept Haematol Athens Greece;
Gen Hosp Patras Agios Andreas Tsertidou 1 Patras 26335 Greece;
Univ Gen Hosp Heraklion Iraklion 71110 Greece;
Univ Athens Sch Med Dept Clin Therapeut Athens Greece;
Univ Gen Hosp Larissa Mezourlo 41110 Larissa Greece;
Univ Athens Propaedeut Dept Internal Med 1 Athens Greece;
Hellen Greek MDS Study Grp Patras 26500 Greece;
Univ Gen Hosp Attikon Dept Internal Med 2 1 Rimini St Athens 12462 Greece;
机译:用5-氮杂辛胺治疗的骨髓增生综合征高风险患者单体核型(MK)的预后价值:Hellenic(希腊语)骨髓增强综合征研究组的回顾性分析
机译:783例原发性骨髓增生异常综合征患者中经修订的IPSS细胞遗传学风险分层和单核染色体核型对预后的影响
机译:骨髓增生异常综合症的部分和全部染色体核型:421名患者的预后相关性。
机译:RAS基因突变在急性髓性白血病和髓细胞增强综合征中:荟萃分析其发生和预后相关性
机译:慢性骨髓衰竭和输血模式:骨髓增生综合征患者出血和结果的流行病学研究
机译:修订后的国际预后评分系统细胞遗传学和单核染色体核型对骨髓增生异常综合症和继发于骨髓增生异常综合症的继发性急性髓性白血病的同种异体干细胞移植后结局的影响:欧洲血液和骨髓移植学会的一项回顾性多中心研究
机译:用5-氮杂辛胺治疗的骨髓增生综合征高危患者单体核型(MK)的预后价值:Hellenic(希腊语)骨髓增生综合征研究组的回顾性分析